Results
|
10941.
|
|
|
10942.
|
|
|
10943.
|
Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma. [electronic resource] by
- Oh, Young Taek
- Cho, Hee Jin
- Kim, Jinkuk
- Lee, Ji-Hyun
- Rho, Kyoohyoung
- Seo, Yun-Jee
- Choi, Yeon-Sook
- Jung, Hye Jin
- Song, Hyeon Suk
- Kong, Doo-Sik
- Seol, Ho Jun
- Lee, Jung-Il
- Yoon, Yeup
- Kim, Sunghoon
- Nam, Do-Hyun
- Joo, Kyeung Min
Producer: 20150423
In:
PloS one vol. 9
Availability: No items available.
|
|
10944.
|
|
|
10945.
|
|
|
10946.
|
|
|
10947.
|
|
|
10948.
|
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance. [electronic resource] by
- Fabbri, Chiara
- Crisafulli, Concetta
- Calati, Raffaella
- Albani, Diego
- Forloni, Gianluigi
- Calabrò, Marco
- Martines, Rosalba
- Kasper, Siegfried
- Zohar, Joseph
- Juven-Wetzler, Alzbeta
- Souery, Daniel
- Montgomery, Stuart
- Mendlewicz, Julien
- Serretti, Alessandro
Producer: 20180613
In:
European archives of psychiatry and clinical neuroscience vol. 267
Availability: No items available.
|
|
10949.
|
|
|
10950.
|
|
|
10951.
|
FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors. [electronic resource] by
- Mendrinou, E
- Patsatsi, A
- Zafiriou, E
- Papadopoulou, D
- Aggelou, L
- Sarri, C
- Mamuris, Z
- Kyriakou, A
- Sotiriadis, D
- Roussaki-Schulze, A
- Sarafidou, T
- Vasilopoulos, Y
Producer: 20180105
In:
The pharmacogenomics journal vol. 17
Availability: No items available.
|
|
10952.
|
|
|
10953.
|
Zebrafish: A Pharmacogenetic Model for Anesthesia. [electronic resource] by
- Bedell, Victoria
- Buglo, Elena
- Marcato, Daniel
- Pylatiuk, Christian
- Mikut, Ralf
- Stegmaier, Johannes
- Scudder, Will
- Wray, Maxwell
- Züchner, Stephan
- Strähle, Uwe
- Peravali, Ravindra
- Dallman, Julia E
Producer: 20190405
In:
Methods in enzymology vol. 602
Availability: No items available.
|
|
10954.
|
rs1800796 of the IL6 gene is associated with increased risk for anti-tuberculosis drug-induced hepatotoxicity in Chinese Han children. [electronic resource] by
- Li, Yingjia
- Tang, Haijing
- Qi, Hui
- Shen, Chen
- Sun, Lin
- Li, Jieqiong
- Xu, Fang
- Jiao, Weiwei
- Yang, Xu
- Shen, Adong
Producer: 20190403
In:
Tuberculosis (Edinburgh, Scotland) vol. 111
Availability: No items available.
|
|
10955.
|
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. [electronic resource] by
- Kakuta, Yoichi
- Kawai, Yosuke
- Okamoto, Daisuke
- Takagawa, Tetsuya
- Ikeya, Kentaro
- Sakuraba, Hirotake
- Nishida, Atsushi
- Nakagawa, Shoko
- Miura, Miki
- Toyonaga, Takahiko
- Onodera, Kei
- Shinozaki, Masaru
- Ishiguro, Yoh
- Mizuno, Shinta
- Takahara, Masahiro
- Yanai, Shunichi
- Hokari, Ryota
- Nakagawa, Tomoo
- Araki, Hiroshi
- Motoya, Satoshi
- Naito, Takeo
- Moroi, Rintaro
- Shiga, Hisashi
- Endo, Katsuya
- Kobayashi, Taku
- Naganuma, Makoto
- Hiraoka, Sakiko
- Matsumoto, Takayuki
- Nakamura, Shiro
- Nakase, Hiroshi
- Hisamatsu, Tadakazu
- Sasaki, Makoto
- Hanai, Hiroyuki
- Andoh, Akira
- Nagasaki, Masao
- Kinouchi, Yoshitaka
- Shimosegawa, Tooru
- Masamune, Atsushi
- Suzuki, Yasuo
Producer: 20190711
In:
Journal of gastroenterology vol. 53
Availability: No items available.
|
|
10956.
|
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer. [electronic resource] by
- Huijberts, Sanne C F A
- van Geel, Robin M J M
- van Brummelen, Emilie M J
- Opdam, Frans L
- Marchetti, Serena
- Steeghs, Neeltje
- Pulleman, Saskia
- Thijssen, Bas
- Rosing, Hilde
- Monkhorst, Kim
- Huitema, Alwin D R
- Beijnen, Jos H
- Bernards, René
- Schellens, Jan H M
Producer: 20201117
In:
Cancer chemotherapy and pharmacology vol. 85
Availability: No items available.
|
|
10957.
|
|
|
10958.
|
|
|
10959.
|
|
|
10960.
|
Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. [electronic resource] by
- McNamara, D M
- Holubkov, R
- Janosko, K
- Palmer, A
- Wang, J J
- MacGowan, G A
- Murali, S
- Rosenblum, W D
- London, B
- Feldman, A M
Producer: 20010524
In:
Circulation vol. 103
Availability: No items available.
|